Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease

CompletedOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

June 30, 2017

Conditions
Coronary DiseaseNon-alcoholic Fatty Liver DiseaseElasticity Imaging Techniques
Interventions
DEVICE

Fibro Scan

GENETIC

PNPLA3

Trial Locations (1)

04103

Leipzig University Medical Center, Leipzig

All Listed Sponsors
collaborator

Universitätsklinikum Leipzig

OTHER

lead

University of Leipzig

OTHER

NCT02779946 - Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease | Biotech Hunter | Biotech Hunter